BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 19122268)

  • 1. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination therapy for osteoporosis].
    Kishimoto H
    Nihon Rinsho; 2009 May; 67(5):975-9. PubMed ID: 19432119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.
    van den Boogaard CH; Breekveldt-Postma NS; Borggreve SE; Goettsch WG; Herings RM
    Curr Med Res Opin; 2006 Sep; 22(9):1757-64. PubMed ID: 16968579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonates].
    Matsumoto T
    Clin Calcium; 2004 Jan; 14(1):145-52. PubMed ID: 15576971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of parathyroid hormone for the treatment of osteoporosis.
    Morley P
    Expert Opin Drug Deliv; 2005 Nov; 2(6):993-1002. PubMed ID: 16296804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
    Garcés C; García LE
    Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of primary osteoporosis in men].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates.
    Danese MD; Badamgarav E; Bauer DC
    J Bone Miner Res; 2009 Nov; 24(11):1819-26. PubMed ID: 19419313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential therapy in the treatment of osteoporosis.
    Boonen S; Milisen K; Gielen E; Vanderschueren D
    Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated approach: bisphosphonate management for the treatment of osteoporosis.
    Owens G; Jackson R; Lewiecki EM
    Am J Manag Care; 2007 Dec; 13 Suppl 11():S290-308; quiz S309-12. PubMed ID: 18095779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug insight: Existing and emerging therapies for osteoporosis.
    Mulder JE; Kolatkar NS; LeBoff MS
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination and sequential therapy with PTH and bisphosphonates.
    Bauer DC
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):407. PubMed ID: 15758282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perspective for development of parathyroid hormone and related compounds as therapeutic agents for osteoporosis].
    Ikeda K; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():367-71. PubMed ID: 16279664
    [No Abstract]   [Full Text] [Related]  

  • 15. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective.
    Boonen S
    Curr Med Res Opin; 2009 Oct; 25(10):2335-41. PubMed ID: 19650755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of osteoporosis in women intolerant of oral bisphosphonates.
    Aspray TJ; Francis RM
    Maturitas; 2012 Jan; 71(1):76-8. PubMed ID: 22079368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].
    Hosoi T
    Clin Calcium; 2009 Jan; 19(1):11-8. PubMed ID: 19122260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].
    Sowa H; Hamaya E; Yamamoto T
    Clin Calcium; 2011 Jan; 21(1):9-16. PubMed ID: 21187589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.